These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 6448165

  • 1. Serotoninergic modulation of mesolimbic and frontal cortical dopamine neurons.
    Waldmeier PC.
    Experientia; 1980 Sep 15; 36(9):1092-4. PubMed ID: 6448165
    [Abstract] [Full Text] [Related]

  • 2. Analysis of the activation of dopamine metabolism by a serotonin uptake inhibitor.
    Waldmeier PC.
    Eur J Pharmacol; 1979 Dec 20; 60(4):315-22. PubMed ID: 527667
    [Abstract] [Full Text] [Related]

  • 3. Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.
    Koulu M, Sjöholm B, Lappalainen J, Virtanen R.
    Eur J Pharmacol; 1989 Oct 10; 169(2-3):321-4. PubMed ID: 2530097
    [Abstract] [Full Text] [Related]

  • 4. Activation of dopamine synthesis in mesolimbic dopamine neurons by immobilization stress in the rat.
    Watanabe H.
    Neuropharmacology; 1984 Nov 10; 23(11):1335-8. PubMed ID: 6441893
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine.
    Toru M, Mataga N, Takashima M, Nishikawa T.
    Psychopharmacology (Berl); 1981 Nov 10; 74(4):316-20. PubMed ID: 6794073
    [Abstract] [Full Text] [Related]

  • 6. Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response.
    Deutch AY, Tam SY, Freeman AS, Bowers MB, Roth RH.
    Eur J Pharmacol; 1987 Feb 24; 134(3):257-64. PubMed ID: 3569414
    [Abstract] [Full Text] [Related]

  • 7. Changes of serotonin and dopamine metabolism in various forebrain areas of rats injected with morphine either systemically or in the raphe nuclei dorsalis and medianus.
    Spampinato U, Esposito E, Romandini S, Samanin R.
    Brain Res; 1985 Feb 25; 328(1):89-95. PubMed ID: 2578858
    [Abstract] [Full Text] [Related]

  • 8. Serotonin--dopamine interactions in the nigrostriatal system.
    Waldmeier PC, Delini-Stula AA.
    Eur J Pharmacol; 1979 May 15; 55(4):363-73. PubMed ID: 572774
    [Abstract] [Full Text] [Related]

  • 9. Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin.
    Kitaichi K, Yamada K, Hasegawa T, Furukawa H, Nabeshima T.
    Jpn J Pharmacol; 1994 Oct 15; 66(2):181-9. PubMed ID: 7532732
    [Abstract] [Full Text] [Related]

  • 10. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
    Broderick PA, Piercey MF.
    J Neural Transm (Vienna); 1998 Oct 15; 105(6-7):749-67. PubMed ID: 9826116
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of dopamine metabolism in rat brain frontal cortex: a common effect of chronically administered antipsychotic drugs.
    Mefford IN, Roth KA, Agren H, Barchas JD.
    Brain Res; 1988 Dec 20; 475(2):380-4. PubMed ID: 2905626
    [Abstract] [Full Text] [Related]

  • 12. Evidence of serotonin involvement in the effect of morphine on dopamine metabolism in the rat nucleus accumbens but not in the striatum.
    Spampinato U, Invernizzi R, Samanin R.
    Pharmacol Res Commun; 1984 May 20; 16(5):519-23. PubMed ID: 6234602
    [Abstract] [Full Text] [Related]

  • 13. Effects of aminooxyacetic acid and baclofen on the catalepsy and on the increase of mesolimbic and striatal dopamine turnover induced by haloperidol in rats.
    Kääriäinen I.
    Acta Pharmacol Toxicol (Copenh); 1976 Sep 20; 39(3):393-400. PubMed ID: 989685
    [No Abstract] [Full Text] [Related]

  • 14. Neurochemical effects of chronic haloperidol and lithium assessed by brain microdialysis in rats.
    Hernandez L, Baptista T, Hoebel BG.
    Prog Neuropsychopharmacol Biol Psychiatry; 1990 Sep 20; 14 Suppl():S17-35. PubMed ID: 2097671
    [Abstract] [Full Text] [Related]

  • 15. Stress and the mesocorticolimbic dopamine systems.
    Roth RH, Tam SY, Ida Y, Yang JX, Deutch AY.
    Ann N Y Acad Sci; 1988 Sep 20; 537():138-47. PubMed ID: 3059920
    [No Abstract] [Full Text] [Related]

  • 16. Haloperidol inhibits the disappearance of acidic dopamine metabolites from rat striatum.
    Moleman P, Bruinvels J, van Valkenburg CF.
    J Pharm Pharmacol; 1978 Sep 20; 30(9):583-5. PubMed ID: 29101
    [No Abstract] [Full Text] [Related]

  • 17. On the relation between haloperidol-induced alterations in DA release and DA metabolism in rat striatum.
    Moleman P, Bruinvels J, van Valkenburg CF.
    Life Sci; 1978 Aug 14; 23(6):611-5. PubMed ID: 692284
    [No Abstract] [Full Text] [Related]

  • 18. Clozapine: reduction of the initial dopamine turnover increase by repeated treatment.
    Waldmeier PC, Maître L.
    Eur J Pharmacol; 1976 Jul 14; 38(1):197-203. PubMed ID: 954831
    [Abstract] [Full Text] [Related]

  • 19. Involvement of striatal dopamine, homovanillic acid and 3,4-dihydroxyphenylacetic acid in the hypothermia and catalepsy induced by haloperidol.
    Massotti M.
    Pharmacol Res Commun; 1977 Apr 14; 9(4):381-9. PubMed ID: 559310
    [No Abstract] [Full Text] [Related]

  • 20. Long-term effects of haloperidol, Clozapine, and methadone on rat striatal cholinergic and dopaminergic dynamics.
    Ladinsky H, Consolo S, Samanin R, Algeri S, Ponzio F.
    Adv Biochem Psychopharmacol; 1980 Apr 14; 24():259-65. PubMed ID: 7405665
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.